Global Custom Market Research Reports Provider Company


OncoMed Pharmaceuticals, Inc. (OMED) - Financial and Strategic SWOT Analysis Review

  • Published Date: 01 Feb 2015
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America


OncoMed Pharmaceuticals, Inc. (OncoMed) is a biotechnology company. The company discovers and develops monoclonal antibody therapeutics. Its product pipeline includes demcizumab, OMP-59R5, vantictumab, OMP-52M51, OMP-54F28, OMP-305B83, and anti-RSPO-LGR, among others. The company also develops targeted antibody and other protein based therapeutics, which are designed to modulate cancer stem cell targets and inhibit the growth of CSCs. It has advanced multiple internally discovered programs for clinical testing. The company partners with GlaxoSmithKline and Bayer HealthCare. OncoMed is headquartered in Redwood, California, the US.

OncoMed Pharmaceuticals, Inc. Key Recent Developments

Nov 27, 2013: OncoMed Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
Oct 21, 2013: OncoMed Presents Data From Clinical Trials of Four Novel Anti-Cancer Stem Cell Therapeutics at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston
Oct 17, 2013: OncoMed Pharmaceuticals Appoints Michael Wyzga to Board of Directors
Oct 09, 2013: OncoMed Pharmaceuticals Receives First U.S. Patent on MAbTrap Antibody Display Technology
Oct 03, 2013: OncoMed Pharmaceuticals to Present at 12th Annual BIO Investor Forum

This comprehensive SWOT profile of OncoMed Pharmaceuticals, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OncoMed Pharmaceuticals, Inc. including: and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief Summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Publisher Name : GlobalData

OncoMed Pharmaceuticals, Inc. - Key Information
OncoMed Pharmaceuticals, Inc. - Overview
OncoMed Pharmaceuticals, Inc. - Key Employees
OncoMed Pharmaceuticals, Inc. - Key Employee Biographies
OncoMed Pharmaceuticals, Inc. - Key Operational Heads
OncoMed Pharmaceuticals, Inc. - Major Products and Services
OncoMed Pharmaceuticals, Inc. - History
OncoMed Pharmaceuticals, Inc. - Company Statement
OncoMed Pharmaceuticals, Inc. - Locations And Subsidiaries
OncoMed Pharmaceuticals, Inc. - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

OncoMed Pharmaceuticals, Inc. - Business Description
OncoMed Pharmaceuticals, Inc. - Corporate Strategy
OncoMed Pharmaceuticals, Inc. - SWOT Analysis
SWOT Analysis - Overview
OncoMed Pharmaceuticals, Inc. - Strengths
OncoMed Pharmaceuticals, Inc. - Weaknesses
OncoMed Pharmaceuticals, Inc. - Opportunities
OncoMed Pharmaceuticals, Inc. - Threats
OncoMed Pharmaceuticals, Inc. - Key Competitors

Section 3 - Company Financial Performance Charts

OncoMed Pharmaceuticals, Inc. - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

OncoMed Pharmaceuticals, Inc., Key Information
OncoMed Pharmaceuticals, Inc., Key Ratios
OncoMed Pharmaceuticals, Inc., Share Data
OncoMed Pharmaceuticals, Inc., Major Products and Services
OncoMed Pharmaceuticals, Inc., History
OncoMed Pharmaceuticals, Inc., Key Employees
OncoMed Pharmaceuticals, Inc., Key Employee Biographies
OncoMed Pharmaceuticals, Inc., Key Operational Heads
OncoMed Pharmaceuticals, Inc., Other Locations
OncoMed Pharmaceuticals, Inc., Subsidiaries
OncoMed Pharmaceuticals, Inc., Key Manufacturing facilities
OncoMed Pharmaceuticals, Inc., Key Competitors
OncoMed Pharmaceuticals, Inc., SWOT Analysis
OncoMed Pharmaceuticals, Inc., Ratios based on current share price
OncoMed Pharmaceuticals, Inc., Annual Ratios
OncoMed Pharmaceuticals, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

OncoMed Pharmaceuticals, Inc., Performance Chart
OncoMed Pharmaceuticals, Inc., Ratio Charts

OncoMed Pharmaceuticals Inc (OncoMed) is a novel therapeutics developer that discovers and develops monoclonal antibody therapeutics that targets cancer stem cells. The companys clinical stage pipeline product candidate includes demcizumab,

View Report

OncoMed Pharmaceuticals Inc (OncoMed) is a novel therapeutics developer that discovers and develops monoclonal antibody therapeutics that targets cancer stem cells. The companys clinical stage pipeline product candidate includes demcizumab,

View Report

OncoMed Pharmaceuticals, Inc. (OMED) - Pharmaceuticals & Healthcare - Deals and Alliances Profile market research report at USD 250 and market update available at JSB Market Research.

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports